
News|Videos|September 12, 2025
David Brousseau, MD: Benefits of timely opioid dosing for SCD pain
Author(s)David Brousseau, MD, MS
Fact checked by: Joshua Fitch, Senior Editor
Study author David Brousseau, MD, MS, explains the benefit of a child being able to go home after a sickle cell disease-associated ED visit.
Advertisement
Advertisement
Children with sickle cell disease (SCD) experiencing acute pain episodes may avoid hospitalization when opioids are administered promptly in the emergency department (ED), according to a recent multisite study
Related to this article

A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.

Pumpkin carving accounts for 55% of Halloween ED injuries; AAOS outlines prevention tips for carving, costumes, and trick-or-treating.

Poison center reports of intentional school exposures rose 287% in elementary and 112% in middle school children from 2000 to 2024.

Emily Becker, MD, discusses the role of AhR agonists, skin barrier function, and steroid-free treatment options for pediatric atopic dermatitis.

Post hoc data show cariprazine improved both manic and depressive symptoms through 52 weeks in youth aged 10 to 17 years with bipolar I disorder.

CDC data show pediatric CP-CRE incidence rose 92% from 2019 to 2024, driven by NDM-CRE, mostly in children with complex medical needs.
Advertisement
Advertisement


